Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Jun 23, 2016
Insider Transaction Report
Form 4
MYERS STEVEN S
Director
Transactions
- Award
Common Stock
2016-06-22+7,500→ 319,431 total - Award
Options to Purchase Common Stock
2016-06-22+12,500→ 12,500 totalExercise: $0.52From: 2017-06-22Exp: 2026-06-22→ Common Stock (12,500 underlying)
Holdings
- 19,531(indirect: By Trust)
Common Stock
- 84,331(indirect: By IRA)
Common Stock
- 8,012(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents 7,500 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on June 22, 2017.
- [F2]Includes 9,000 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 25, 2017 and 7,500 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on June 22, 2017.